Overview

The Effect of Azithromycin on BCT197 Exposure in Healthy Male Volunteers

Status:
Completed
Trial end date:
2016-10-01
Target enrollment:
Participant gender:
Summary
An open-label, single-sequence study to evaluate the effect of azithromycin on BCT197 exposure in healthy male subjects.
Phase:
Phase 1
Details
Lead Sponsor:
Mereo BioPharma
Treatments:
Acumapimod
Azithromycin